We operate comprehensive platforms for stable integrative transformation, CRISPR-based genome editing, and regeneration of engineered events across diverse plant species. Capabilities include method and technology development for customized collaborative projects; i.e. exploratory projects, new species or cultivar, new protocols, , vector preparation, delivery optimization, and molecular validation. Greenhouse and growth chambers support full lifecycle evaluation.

Capabilities

• Agrobacterium transformation (dicots & monocots)
• Biolistic transformation (including chloroplast targets)
• Protoplast transfection and transient expression
• CRISPR (Cas9/Cas12a), multiplex editing, base/prime editing workflows
• PCR/qPCR/RT-PCR, genotyping, Sanger/amplicon validation
• GFP and brightfield imaging; phenotype assessment
• Access to genomics & DNA sequencing capabilities via URI core

Subpages

• Collaborations: how to partner, scopes, timelines
• Training: workshops and hands-on formats
• Contracts: How to set up collaborative contracts, fee-for-service, MTAs, IP, compliance